Comprehensive Cancer Centers looks at how family history can impact genetic cancer risks and how people diagnosed with cancers are treated.
Comprehensive Cancer Centers emphasizes taking the time to mitigate cancer and other health risks through preventative steps. This includes watching your diet, being active with exercise, being safe in the sun, and avoiding alcohol and tobacco. While these measures help, cancer is a disease of the genome, resulting from the accumulation of mutations that lead to uncontrolled cellular proliferation, making genetic mutations and family history factors the most important elements in assessing cancer risks.
In the vast majority of cases, mutations are acquired during a person’s lifetime due to environmental exposures, aging, or errors in DNA replication. These cancers are known as sporadic cancers. In 5-10% of these cases, an individual inherits a defective copy of a gene that dramatically increases susceptibility to developing cancer. This inherited predisposition forms the basis of hereditary cancer syndromes. Understanding these hereditary factors through family history is crucial for targeted prevention, enhanced surveillance, and personalized medical intervention.
The Genetic Blueprint: Oncogenes and Tumor Suppressors
To understand hereditary cancer, one must first grasp the role of two main classes of genes responsible for regulating cell growth and repair: oncogenes and tumor suppressor genes (TSGs).
- Oncogenes: These are typically mutated versions of normal genes (proto-oncogenes) that accelerate cell division. Think of them as the cell’s gas pedal. A mutation in a single copy of an oncogene may be enough to drive a cell toward malignancy. These mutations are rarely inherited in the germline.
- Tumor Suppressor Genes (TSGs): These genes act as the cell’s brakes, repairing DNA damage, slowing down division, or initiating programmed cell death (apoptosis). They require mutations in both copies of the gene to fail entirely.
Hereditary cancer syndromes are overwhelmingly caused by inheriting a defective, inactive copy (a germline mutation) of a TSG. This is known as Knudson’s “two-hit hypothesis”: the first hit (the inherited mutation) is present in every cell, and the second hit (an acquired mutation due to environmental factors or chance) causes the loss of the functional copy, leading to the rapid, uncontrolled growth of a tumor.
Key Family History Cancer Syndromes and Associated Genes
Dozens of genes are implicated in hereditary cancer, but three major syndromes account for the largest proportion of inherited risk, each governed by specific tumor suppressor genes:
Hereditary Breast and Ovarian Cancer (HBOC): HBOC is most commonly associated with mutations in the BRCA1 and BRCA2 genes. These genes are involved in DNA repair, specifically through homologous recombination. When they are mutated, the cell loses a critical mechanism for fixing double-strand breaks in DNA, leading to genomic instability and a high risk of malignancy.
Risk Implications: A woman inheriting a mutated gene has a lifetime risk of breast cancer up to 85% and an ovarian cancer risk ranging from 15% to 44%. Other Associated Cancers: These genes also elevate the risk for other cancers, including prostate cancer, pancreatic cancer, and melanoma. Inheritance: Autosomal dominant (a child of a carrier has a 50% chance of inheriting the mutation).
Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer, HNPCC): Lynch syndrome is the most common cause of hereditary colorectal cancer and is caused by mutations in genes responsible for DNA mismatch repair (MMR). The MMR system corrects small errors made during DNA replication. When this system fails, the resulting high mutation rate in cells quickly accelerates cancer development.
Risk Implications: Individuals with Lynch syndrome have a significantly increased lifetime risk of colorectal cancer (up to 80%) and endometrial cancer (up to 60%). Colorectal tumors often develop much earlier, frequently before age 50. Other Associated Cancers: gastric, ovarian, urinary tract, hepatobiliary, and small bowel cancers are also at elevated risk. Inheritance: Autosomal dominant.
Familial Adenomatous Polyposis (FAP): FAP is a rare but highly penetrant syndrome caused by a mutation in the Adenomatous Polyposis Coli gene. APC controls cell proliferation in the colon lining. A non-functional APC leads to the growth of hundreds to thousands of precancerous polyps (adenomas) throughout the colon and rectum, typically beginning in adolescence.
Risk Implications: Without preventative intervention, individuals with FAP have a near 100% lifetime risk of developing colorectal cancer, usually by age 40. Intervention: Prophylactic colectomy (surgical removal of the colon) is often recommended to prevent inevitable cancer development. Inheritance: Autosomal dominant.
The Importance of Family History and Genetic Counseling
The single most valuable screening tool for identifying a potential hereditary cancer risk is a detailed family health history. Individuals should be referred for genetic counseling, offered by Comprehensive Cancer Centers if personal and/or family history includes cancer diagnoses before 50, multiple cancers, family members with cancers, and rare cancers, such as male breast cancer.
Testing involves analyzing DNA, usually from a blood or saliva sample, to look for specific germline mutations. Results can be categorized as: Positive: A known pathogenic mutation is identified, prompting enhanced surveillance and risk-reduction strategies. Negative: No mutation is found, reducing, but not eliminating, risk.
Variant of Uncertain Significance (VUS): A change in the gene is found, but its clinical impact is currently unknown. VUS results complicate management and usually require follow-up testing or clarification over time.
Risk Management: Interacting with Modifiable Factors
Although inherited genes cannot be changed, genetic risk does not determine your future. A diagnosis of a hereditary cancer syndrome simply clarifies the risk and allows for aggressive, proactive management. These management strategies often involve combining medical interventions with healthy lifestyle choices.
Hereditary factors play a targeted and profound role in cancer risks. Identifying a germline mutation is not a verdict but a clear call to action. Through accurate genetic counseling and testing, combined with aggressive preventative and surveillance protocols, individuals with inherited predispositions can dramatically mitigate their risk, transforming a genetic vulnerability into an opportunity for personalized health management.
Comprehensive Cancer Centers Can Help
Physicians at Comprehensive Cancer Centers offer a wide range of preventive strategies to help reduce cancer and other health risks, as well as advanced treatment options for patients already diagnosed with cancer—all right here in Southern Nevada. Learn more about genetic counseling at Comprehensive Cancer Centers, please call 702-952-3350.
The content in this post is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of qualified health providers with questions you may have regarding medical conditions.
